Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance

• Stine U. Mikkelsen,
• Setareh Safavi,
• Konstantinos Dimopoulos,
• Colm J. O’Rourke,
• Mette K. Andersen,
• Mette S. Holm,
• Claus W. Marcher,
• Jesper B. Andersen,
• Jakob W. Hansen,
• Kirsten Grønbæk

Affiliations

Stine U. Mikkelsen

Department of Hematology, Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen

Setareh Safavi

Department of Clinical Genetics, Rigshospitalet, Copenhagen

Konstantinos Dimopoulos

Department of Clinical Biochemistry, Rigshospitalet, Copenhagen

Colm J. O’Rourke

Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen

Mette K. Andersen

Department of Clinical Genetics, Rigshospitalet, Copenhagen

Mette S. Holm

Department of Hematology, Aarhus University Hospital, Aarhus

Claus W. Marcher

Department of Hematology, Odense University Hospital, Odense

Jesper B. Andersen

Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen

Jakob W. Hansen

Department of Hematology, Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; DanStem, University of Copenhagen, Copenhagen

Kirsten Grønbæk

Department of Hematology, Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; DanStem, University of Copenhagen, Copenhagen